Skip to content
★ Sign in to follow
DG

David G. Ichikawa

Sangamo Therapeutics, Inc
Total declarations
80
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (71 ops.)
€477k

Latest filing published 12 Dec 2011 for Sangamo Therapeutics, INC.

Insider track record

Disclosed buys
0
Disclosed sells
71
Signal history

No signal scores available.

David G. Ichikawa: trading record in brief

David G. Ichikawa discloses dealings in Sangamo Therapeutics, Inc to SEC (Form 4). The record holds 80 filings, for trades running from 15 January 2008 to 8 December 2011.

Sales make up the whole of the open-market record (71 sales, €477k). Outside the open market, there are 1 share grant and 8 option exercises. In 2011 alone, the filings show no purchases and 12 sales.

The latest filing, published on 12 December 2011, reports a share grant in Sangamo Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to David G. Ichikawa

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations80 total

25 of 80 declarations